BRIEF — JCR Pharmaceuticals Receives Marketing Authorization In Kuwait For Izcargo

Oct 14 (Reuters) — JCR Pharmaceuticals Co., Ltd.: Jcr Pharmaceuticals Receives Marketing Authorization In Kuwait For Izcargo™, A Blood-brain Barrier-penetrating Enzyme Replacement Therapy For Hunter Syndrome Jcr Pharmaceuticals Co. - To Seek Marketing Authorization For Izcargo In Mena Region; Taiba To Handle Sales Jcr Pharmaceuticals Co.,.: Impact Of Announcement On Jcr's Consolidated Financial Results For This Fiscal Year Is Expected To Be Minor (Reuters.Briefs@thomsonreuters.com;)